Join our advanced solid tumor clinical trial


Have you been diagnosed with PIK3CA Mutant Clear Cell Ovarian, Endometrial, Colorectal Cancer? You may be eligible to participate in our clinical study of Serabelisib in Combination with an Insulin Suppressing Diet. 

Contact us today to find out if you are eligible to join our clinical trial.

Thanks for submitting!


SER-ISD1-001:  A Phase 1b Study of Serabelisib in Combination with an Insulin Suppressing Diet (Study ISD) in Adult Subjects with Advanced Solid Tumors with PIK3CA Mutations with or without PTEN loss


  • University of Alabama, Birmingham AL

  • Hoag, Newport Beach CA

  • Pacific Cancer Specialists, Anaheim CA 

  • WCRN-COGI, Fresno CA

  • Valkyrie Clinical Trials, Los Angeles CA

  • University of Chicago, Chicago IL 

  • Mayo Clinic, Rochester MN

  • East Carolina University, Greenville NC

  • Memorial Sloan Kettering, New York NY

  • University of Pennsylvania, Philadelphia PA

  • Avera, Sioux Falls SD

  • Baptist Hospitals of Southeast Texas, Beaumont TX

  • University of Texas Southwestern, Dallas TX 

  • Medical College of Wisconsin, Milwaukee WI

Find out if you are eligible

Learn more at

Questions? Contact us, we're here to help

We are committed to your fight, and to creating better cancer treatments for you and many others like you in the future.